Zacks: Brokerages Anticipate U.S. Physical Therapy, Inc. (USPH) Will Announce Earnings of $0.55 Per Share

Equities analysts predict that U.S. Physical Therapy, Inc. (NYSE:USPH) will post earnings of $0.55 per share for the current quarter, Zacks reports. Two analysts have issued estimates for U.S. Physical Therapy’s earnings, with the lowest EPS estimate coming in at $0.54 and the highest estimate coming in at $0.55. U.S. Physical Therapy reported earnings of $0.51 per share during the same quarter last year, which indicates a positive year over year growth rate of 7.8%. The firm is scheduled to issue its next earnings report before the market opens on Thursday, May 3rd.

According to Zacks, analysts expect that U.S. Physical Therapy will report full year earnings of $2.44 per share for the current year, with EPS estimates ranging from $2.38 to $2.50. For the next year, analysts anticipate that the company will post earnings of $2.59 per share, with EPS estimates ranging from $2.51 to $2.68. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that that provide coverage for U.S. Physical Therapy.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, March 8th. The company reported $0.49 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.49. U.S. Physical Therapy had a return on equity of 13.12% and a net margin of 5.38%. The company had revenue of $109.20 million for the quarter, compared to analyst estimates of $104.12 million.

Several equities analysts have recently issued reports on the company. Cantor Fitzgerald reiterated a “buy” rating and issued a $80.00 price target on shares of U.S. Physical Therapy in a research note on Tuesday, January 9th. Barrington Research reissued a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, March 9th. Zacks Investment Research downgraded U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Friday, March 9th. Jefferies Group set a $76.00 price objective on U.S. Physical Therapy and gave the company a “hold” rating in a report on Friday, February 23rd. Finally, ValuEngine raised U.S. Physical Therapy from a “hold” rating to a “buy” rating in a report on Monday, April 2nd. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $79.40.

Shares of USPH traded up $1.60 during midday trading on Monday, hitting $94.45. The company’s stock had a trading volume of 42,427 shares, compared to its average volume of 51,911. U.S. Physical Therapy has a one year low of $56.50 and a one year high of $94.45. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.95 and a current ratio of 1.95. The firm has a market cap of $1,168.16, a price-to-earnings ratio of 45.41, a PEG ratio of 3.39 and a beta of 1.08.

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 13th. Investors of record on Wednesday, March 21st were issued a dividend of $0.23 per share. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.20. The ex-dividend date was Tuesday, March 20th. This represents a $0.92 annualized dividend and a dividend yield of 0.97%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 44.23%.

In related news, Director Bernard A. Harris, Jr. sold 6,000 shares of the firm’s stock in a transaction on Monday, March 12th. The stock was sold at an average price of $86.53, for a total transaction of $519,180.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Lawrance W. Mcafee sold 2,000 shares of the firm’s stock in a transaction on Monday, March 12th. The shares were sold at an average price of $86.06, for a total value of $172,120.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 18,643 shares of company stock worth $1,583,645. 2.50% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. SG Americas Securities LLC acquired a new position in U.S. Physical Therapy during the 3rd quarter worth about $170,000. UBS Asset Management Americas Inc. acquired a new position in U.S. Physical Therapy during the 4th quarter worth about $206,000. Ladenburg Thalmann Financial Services Inc. lifted its holdings in U.S. Physical Therapy by 59.9% during the 3rd quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,770 shares of the company’s stock worth $231,000 after buying an additional 1,412 shares during the period. Envestnet Asset Management Inc. lifted its holdings in U.S. Physical Therapy by 48.6% during the 4th quarter. Envestnet Asset Management Inc. now owns 3,704 shares of the company’s stock worth $267,000 after buying an additional 1,212 shares during the period. Finally, Trustcore Financial Services LLC acquired a new position in U.S. Physical Therapy during the 4th quarter worth about $296,000. 96.46% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Zacks: Brokerages Anticipate U.S. Physical Therapy, Inc. (USPH) Will Announce Earnings of $0.55 Per Share” was published by Markets Daily and is the property of of Markets Daily. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.themarketsdaily.com/2018/04/23/zacks-brokerages-anticipate-u-s-physical-therapy-inc-usph-will-announce-earnings-of-0-55-per-share.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply